Price (delayed)
$44.28
Market cap
$3.42B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.94
Enterprise value
$3.29B
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally
There are no recent dividends present for PTCT.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.